Safety of Thulium Fiber Laser Litothripsy in the Management of Large Renal Stones (>1000 mm³) and Factors Affecting Treatment Success
RIRS and TFL
2 other identifiers
interventional
81
1 country
1
Brief Summary
The aim of this study is to compare the efficacy and safety of Thulium Fiber Laser (TFL) litothripsy according to stone density and the factors affecting success in patients undergoing retrograde intrarenal surgery (RIRS) for renal calculi \>1000 mm3. Between November 2023 and December 2024, 81 patients with a stone volume \>1000 mm3 who underwent RIRS with TFL in our clinic were prospectively and sequentially evaluated. Stone density of the patients was measured, and expressed in Hounsfield Units (HU). Patients with stone densities \<1000 HU and ≥1000 HU were categorized as Groups 1, and 2, respectively. Demographic data, data of intraoperative laser use, stone-free rates (SFRs), the need for a second session of RIRS and complications were recorded. Duration of TFL litothripsy, total energy used, laser ablation speed (mm3/sec), laser ablation efficiency (mm3/J) and laser energy consumption (J/mm3) were calculated. Correlation tests, univariate and multivariate logistic regression tests were used for statistical analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
July 17, 2025
CompletedFirst Posted
Study publicly available on registry
September 4, 2025
CompletedSeptember 4, 2025
August 1, 2025
1.1 years
July 17, 2025
August 31, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome was to assess the effectiveness of the laser.
Fragmentation success was used to evaluate the laser effectiveness of laser.
12 months
Secondary Outcomes (1)
The secondary outcome was the evaluation of factors affecting stone-free rates
3 months
Study Arms (1)
Safety and Efficacy of Thulium Fiber Laser for Large Renal Stones
EXPERIMENTALDemographic data (age, gender, body mass index (BMI)), stone characteristics (size, location, Hounsfield Unit (HU) value) and durations of the procedures were recorded. Patients over 18 years of age, with kidney stones larger than 1000 mm³, single or multiple stones and those eligible for RIRS were included in the study. Patients under 18 years of age, those with bleeding diathesis or inability to discontinue anticoagulant/antiaggregant therapy, cases with a history of previous RIRS, individuals who did not attend follow-up visits, patients in whom postoperative residual stone assessment could not be made, or had concomitant bladder or ureteral stones were excluded. SFRs, the need for a second session of RIRS and complications were noted. General anesthesia was used. Rigid ureteroscope was inserted through urethral meatus. 11/13 F ureteral sheath was advanced over guidewire under fluoroscopy. Laser settings varied 0.2J/100Hz to 1J/10Hz based on stone fragility.
Interventions
While literature studies on TFL have focused on the effect of stone size on laser efficacy parameters, the present study is important as it is a prospective study examining the effects of TFL lithotripsy on SFRs in stones \>1000 mm3.
Eligibility Criteria
You may qualify if:
- Patients ≥18 years of age
- Presence of kidney stones larger than 1000 mm³
- Patients with single or multiple kidney stones
- Patients eligible for retrograde intrarenal surgery (RIRS)
You may not qualify if:
- Patients younger than 18 years
- Pregnant or breastfeeding women
- Patients with uncorrected coagulopathy
- Patients with active urinary tract infection
- Patients with severe anatomic abnormalities preventing RIRS
- Patients unwilling or unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Muharrem Baturulead
- University of Gaziantepcollaborator
Study Sites (1)
University of Gaziantep
Gaziantep, Şehitkamil, 27310, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
July 17, 2025
First Posted
September 4, 2025
Study Start
November 1, 2023
Primary Completion
December 1, 2024
Study Completion
June 1, 2025
Last Updated
September 4, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP